DUBLIN, May 11, 2021 / PRNewswire / – Diabetes Injection Pens – Global Market Trajectory & Analytics report has been added to ResearchAndMarkets.com’s offering.
In the midst of the COVID-19 crisis, the global market for diabetes injection pens is estimated at $ 7.2 billion a revised size of is to be achieved in 2020 $ 11.3 billion by 2027 with a CAGR of 6.7% in the period 2020-2027.
Type I diabetes, one of the segments analyzed in the report, is said to have a CAGR of 6.5% and a range of 6.5% $ 6.2 billion until the end of the analysis period. After an early analysis of the business impact of the pandemic and its triggered economic crisis, growth in the Type II diabetes segment will be adjusted to a revised CAGR of 6.9% for the next 7 year period.
The US market is estimated at $ 2 billionWhile China is forecasting growth of 10.1% CAGR
The diabetes injection pen market in the United States is valued at $ 2 billion in 2020. ChinaThe world’s second largest economy is expected to have a forecast market size of $ 2.5 billion By 2027, the CAGR in the analysis period 2020 to 2027 was 10.1%. Other notable geographic markets include Japan and CanadaGrowth of 3.7% and 6% is forecast for the period 2020-2027. Within Europe, Germany is expected to grow by approximately 4.3% CAGR.
Selected competitors (43 recommended in total):
- AstraZeneca PLC
- Becton, Dickinson and Company
- Biocon Ltd.
- Eli Lilly and Company
- Jiangsu Delphi Medical Device Co., Ltd.
- Novo Nordisk A / S.
- Owen Mumford Ltd.
- Wockhardt Ltd.
Main topics covered:
1. MARKET OVERVIEW
- Influencer Market Insights
- World market trends
- Effects of Covid-19 and an impending global recession
2. FOCUS ON SELECTED PLAYERS
3. MARKET TRENDS & DRIVERS
4. PERSPECTIVE OF THE GLOBAL MARKET
III. MARKET ANALYSIS
- UNITED STATES
- UNITED KINGDOM
- THE REST OF EUROPE
- ASIA PACIFIC
- SOUTH KOREA
- THE REST OF ASIA PACIFIC
- LATIN AMERICA
- THE REST OF LATIN AMERICA
- MIDDLE EAST
- SAUDI ARABIA
- UNITED ARAB EMIRATES
- THE REST OF MIDDLE EAST
- Profiled companies in total: 43
Please visit https://www.researchandmarkets.com/r/fz4dcf for more information on this report
Research and Markets
Laura Wood, Senior manager
For EST office hours, call + 1-917-300-0470
For Toll Free US / CAN, call + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900
US Fax: 646-607-1907
Fax (outside the US): + 353-1-481-1716
SOURCE RESEARCH and Markets